In this episode, Gary Bisbee speaks with Dan Liljenquist, Board Chair, CivicaRx, Chief Strategy Officer, Intermountain Healthcare, about the innovative idea of a non profit drug company. They discuss questions of regulation and distribution, and they speak of the broader impact this new model will have on drug prices across the market.